CAS 13182-89-3|Metronidazole Benzoate
| Common Name | Metronidazole Benzoate | ||
|---|---|---|---|
| CAS Number | 13182-89-3 | Molecular Weight | 194.184 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 372.3±27.0 °C at 760 mmHg |
| Molecular Formula | C13H13N3O4 | Melting Point | 102 °C |
| MSDS | / | Flash Point | 150.5±17.2 °C |
Names
| Name | metronidazole benzoate |
|---|---|
| Synonym | More Synonyms |
Metronidazole Benzoate BiologicalActivity
| Description | Metronidazole Benzoate, derives from a metronidazole and a benzoic acid, has a role as an antibacterial, antimicrobial, antiparasitic, and antitrichomonal agent[1]. |
|---|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Anti-infection >>Bacterial |
| Target | Antibacterial, antimicrobial, antiparasitic, antitrichomonal[1] |
| In Vitro | Metronidazole Benzoate is indicated for the treatment of infections caused by a wide range of anaerobic, protozoan and bacteroid bacteria, including trichomoniasis, amebiasis, vaginosis and gingivitis[1]. |
| References | [1]. Santiago de Oliveira Y, et al. The design of novel metronidazole benzoate structures: exploring stoichiometric diversity. Acta Crystallogr C Struct Chem. 2019 May 1;75(Pt 5):483-495. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 372.3±27.0 °C at 760 mmHg |
| Melting Point | 102 °C |
| Molecular Formula | C13H13N3O4 |
| Molecular Weight | 194.184 |
| Flash Point | 150.5±17.2 °C |
| Exact Mass | 194.057907 |
| PSA | 89.94000 |
| LogP | 1.64 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.627 |
| InChIKey | CUUCCLJJOWSASK-UHFFFAOYSA-N |
| SMILES | Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccccc1 |
Safety Information
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2933990090 |
Customs
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles7
More Articles| The treatment of Trichomonas vaginalis vaginitis. An open controlled prospective study comparing a single dose of metronidazole tablets, benzoyl metronidazole suspension and tinidazole tablets. S. Afr. Med. J. 67(12) , 455-7, (1985) Metronidazole tablets, benzoyl metronidazole suspension and tinidazole tablets each given as a single 2 g bolus dose in an open controlled prospective study were found to be effective forms of treatme... | |
| Use of Klion suspension in paediatry and gynaecology. Ther. Hung. 40(4) , 189-91, (1992) Klion suspension was given to 42 girl and woman patients suffering from vaginal trichomoniasis. Negativity for Trichomonas was recorded in 73.8% of the cases in response to the first 10-day cure, and ... | |
| Trichomonas infection in pregnancy--does it affect perinatal outcome? S. Afr. Med. J. 63(15) , 566-7, (1983) Antenatal patients free of Trichomonas vaginalis vaginal infection were compared with infected patients, half of whom were treated and half left untreated. The treated group was given benzoylmetronida... |
Synonyms
| (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid |
| caffeic acid 3-methyl ether |
| Benzoylmetronildazole |
| Coniferic acid |
| (E)-4-hydroxy-3-methoxy-Cinnamic acid |
| (E)-4-Hydroxy-3-methoxycinnamic acid |
| MFCD00239523 |
| (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid |
| 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (2E)- |
| Metronidazole Benzoate |
| (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid |
| (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
| (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
| 2-Methyl-5-nitro-1H-imidazole-1-ethyl benzoate |
| Ferulic acid |
| Ferulic acid, trans- |
| 3-(4-Hydroxy-3-methoxyphenyl)propenoic acid |
| 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl benzoate |
| (2E)-3-(4-Hydroxy-3-methoxyphenyl)acrylic acid |
| EINECS 236-131-7 |
| 1H-Imidazole-1-ethanol, 2-methyl-5-nitro-, benzoate (ester) |
| Ferulic acid, E- |
